Nicole B. Godfrey & Laura L. Rovner.
As of November 12, 2020, at least 182,593 people incarcerated in American prisons, jails, and detention centers have tested positive for COVID-19; 1,412 incarcerated people have died. As the disease spread rapidly across the country (and world) in March 2020, public and prison health experts warned that jails and prisons could become incubators of the highly infectious disease. Recognizing the risk posed to the nation’s incarcerated population, public health officials issued interim guidance meant to assist prison officials seeking to protect the health and safety of incarcerated people. Simultaneously, prisoners’ rights advocates across the country filed lawsuits seeking to ensure prison systems protect incarcerated people from the risk posed by COVID-19.
In response to these lawsuits and the public health guidance, crowded prison systems are returning to an old solution to address prison problems: solitary confinement. The harms associated with solitary confinement are well documented. Within days of being subjected to solitary confinement, individuals experience abnormal patterns in brain activity and quickly lose the ability to concentrate and focus. People in solitary confinement suffer from hypertension, headaches, dizziness, panic attacks, depression, and paranoia. Despite these well-known psychological harms caused by placement in isolating conditions, federal courts considering challenges to prison systems’ responses to COVID-19 have largely, albeit implicitly, credited prison official defendants for embracing solitary as a way to stem the spread of the virus.